Correlation Between Veracyte and CG Oncology,
Can any of the company-specific risk be diversified away by investing in both Veracyte and CG Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and CG Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and CG Oncology, Common, you can compare the effects of market volatilities on Veracyte and CG Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of CG Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and CG Oncology,.
Diversification Opportunities for Veracyte and CG Oncology,
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Veracyte and CGON is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and CG Oncology, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CG Oncology, Common and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with CG Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CG Oncology, Common has no effect on the direction of Veracyte i.e., Veracyte and CG Oncology, go up and down completely randomly.
Pair Corralation between Veracyte and CG Oncology,
Given the investment horizon of 90 days Veracyte is expected to generate 0.84 times more return on investment than CG Oncology,. However, Veracyte is 1.19 times less risky than CG Oncology,. It trades about 0.06 of its potential returns per unit of risk. CG Oncology, Common is currently generating about 0.01 per unit of risk. If you would invest 2,676 in Veracyte on September 4, 2024 and sell it today you would earn a total of 1,736 from holding Veracyte or generate 64.87% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 58.18% |
| Values | Daily Returns |
Veracyte vs. CG Oncology, Common
Performance |
| Timeline |
| Veracyte |
| CG Oncology, Common |
Veracyte and CG Oncology, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Veracyte and CG Oncology,
The main advantage of trading using opposite Veracyte and CG Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, CG Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CG Oncology, will offset losses from the drop in CG Oncology,'s long position.| Veracyte vs. Crinetics Pharmaceuticals | Veracyte vs. Viridian Therapeutics | Veracyte vs. Cytokinetics | Veracyte vs. Structure Therapeutics American |
| CG Oncology, vs. Balchem | CG Oncology, vs. Nabors Industries | CG Oncology, vs. Seadrill Limited | CG Oncology, vs. Ecovyst |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |